Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-907
Closed -$12K – 8275
2017
Q2
$12K Buy
+907
New +$13.1K ﹤0.01% 6684
2016
Q3
– Sell
-2,083
Closed -$20K – 8188
2016
Q2
$20K Buy
2,083
+173
+9% +$1.76K ﹤0.01% 6328
2016
Q1
$19K Buy
+1,910
New +$18.5K ﹤0.01% 6266
2015
Q4
– Sell
-356
Closed -$3K – 8760
2015
Q3
$3K Sell
356
-308
-46% -$2.8K ﹤0.01% 8000
2015
Q2
$7K Buy
664
+625
+1,603% +$5.77K ﹤0.01% 7738
2015
Q1
$0 Sell
39
-858
-96% -$6.73K ﹤0.01% 9797
2014
Q4
$7K Buy
+897
New +$6.83K ﹤0.01% 8752

UBS Group's SEV Position: Q3 2017 in Review

UBS Group sold out of Sevcon (SEV) in Q3 2017, closing a stake of 907 shares — an estimated $12K sold.

UBS Group first reported a position in SEV in Q4 2014 and held it in 7 quarters. The position peaked at $20K in Q2 2016. 0 funds tracked by Wall St. Rank hold SEV as of Q3 2017.

  • UBS Group reported no remaining Sevcon position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 907 Sevcon shares in Q3 2017, an estimated $12K.
  • UBS Group first reported a position in Sevcon in Q4 2014 and held it in 7 quarters.
  • UBS Group's Sevcon position peaked at $20K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sevcon as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.